There’s Still Time to Buy Perspective Therapeutics Inc (AMEX:CATX) Stock

In yesterday’s Wall Street session, Perspective Therapeutics Inc (AMEX:CATX) shares traded at $1.33, up 5.56% from the previous session.

CATX stock price is now -13.66% away from the 50-day moving average and 69.86% away from the 200-day moving average. The market capitalization of the company currently stands at $896.61M.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Sponsored

In other news, Woods Lori A, Director bought 34,246 shares of the company’s stock on Jun 03 ’24. The stock was bought for $49,992 at an average price of $1.46. Upon completion of the transaction, the Director now directly owns 1,553,984 shares in the company, valued at $2.07 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 31 ’24, Director Williamson Robert F III bought 55,000 shares of the business’s stock. A total of $75,900 was incurred on buying the stock at an average price of $1.38. This leaves the insider owning 423,792 shares of the company worth $0.56 million. A total of 23.23% of the company’s stock is owned by insiders.

During the past 12 months, Perspective Therapeutics Inc has had a low of $0.20 and a high of $1.90. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 12.98, and a quick ratio of 12.98. The fifty day moving average price for CATX is $1.5404 and a two-hundred day moving average price translates $0.7831 for the stock.

The latest earnings results from Perspective Therapeutics Inc (AMEX: CATX) was released for 2024-03-31. The net profit margin was -270.46% and return on equity was -29.53% for CATX. The company reported revenue of $0.33 million for the quarter, compared to $0.23 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 39.48 percent.

Related Posts